Taipei, Taiwan

Po-Li Wei


Average Co-Inventor Count = 12.6

ph-index = 1


Company Filing History:


Years Active: 2013-2023

Loading Chart...
3 patents (USPTO):

Title: Po-Li Wei: Innovator in Cancer Research

Introduction

Po-Li Wei is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 3 patents, Wei's work focuses on developing antibodies and methods for cancer detection and treatment.

Latest Patents

One of Wei's latest patents is related to anti-EGF like domain multiple 6 (EGFL6) antibodies. This invention pertains to the creation of anti-EGFL6 antibodies, specifically single-chain antibody fragments (scFv) and humanized antibodies. These antibodies have shown the ability to bind to EGFL6, inhibiting angiogenesis and cancer cell growth. Another significant patent involves a method for identifying candidate compounds that may inhibit α9-nAChR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells. This invention highlights the role of the α9-nAChR promoter and its interaction with estrogen receptors, indicating its importance in cancer response mechanisms.

Career Highlights

Po-Li Wei has worked with esteemed institutions such as Taipei Medical University and Changhua Christian Medical Foundation Changhua Christian Hospital. His research has been pivotal in advancing cancer treatment methodologies and understanding the underlying mechanisms of cancer cell proliferation.

Collaborations

Wei has collaborated with notable colleagues, including Chia-Hwa Lee and Ching-Shyang Chen, contributing to a rich environment of innovation and research in cancer studies.

Conclusion

Po-Li Wei's contributions to cancer research through his patents and collaborations underscore his role as a significant inventor in the field. His work continues to pave the way for advancements in cancer detection and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…